Importer of Controlled Substances Application: Noramco, Inc., 45307 [2016-16550]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 134 / Wednesday, July 13, 2016 / Notices
company plans to import phenylacetone
(8501) and poppy straw concentrate
(9670) to manufacture other controlled
substances.
Dated: July 5, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–16551 Filed 7–12–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on April
4, 2016, Noramco, Inc., 1440 Olympic
Drive, Athens, Georgia 30601 applied to
be registered as an importer of the
following basic classes of controlled
substances:
Drug Enforcement Administration
Controlled substance
Schedule
[Docket No. DEA–392]
Phenylacetone (8501) ..................
Thebaine (9333) ...........................
Poppy Straw Concentrate (9670)
Tapentadol (9780) ........................
Importer of Controlled Substances
Application: Noramco, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before August 12, 2016. Such persons
may also file a written request for a
hearing on the application pursuant to
21 CFR 1301.43 on or before August 12,
2016.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/ODW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments and requests for hearings on
applications to import narcotic raw
material are not appropriate. 72 FR 3417
(January 25, 2007).
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers
importers, and exporters of, controlled
substances (other than final orders in
connection with suspension, denial, or
DATES:
jstallworth on DSK7TPTVN1PROD with NOTICES
II
II
II
II
VerDate Sep<11>2014
15:08 Jul 12, 2016
Jkt 238001
The company plans to import
thebaine derivatives (9333) as reference
standards. The company plans to import
an intermediate form of tapentadol
(9780) to bulk manufacture tapentadol
for distribution to its customers. The
company plans to import phenylacetone
(8501) and poppy straw concentrate
(9670) to manufacture other controlled
substances.
Dated: July 5, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–16550 Filed 7–12–16; 8:45 am]
BILLING CODE 4410–09–P
45307
This meeting is also available
telephonically and by WebEx. You must
use a touch-tone phone to participate in
this meeting. Any interested person may
dial the USA toll number 1–630–395–
0279 or toll free number 1–888–989–
4389, Passcode: 3927350 followed by
the # sign for both days. To join via
WebEx, the link is https://
nasa.webex.com/, the meeting number
for July 28 is 991 445 749 and the
password is nacgrc0728* (case
sensitive). The meeting number for July
29 is 998 630 315 and the password is
nacgrc0729+ (case sensitive).
The agenda for the meeting will
include reports from the following:
—Aeronautics Committee
—Human Exploration and Operations
Committee
—Institutional Committee
—Science Committee
—Technology, Innovation and
Engineering Committee
—Ad Hoc Task Force on STEM
Education
Attendees will be required to sign a
register. It is imperative that the meeting
be held on this date to accommodate the
scheduling priorities of the key
participants.
Patricia D. Rausch,
Advisory Committee Management Officer,
National Aeronautics and Space
Administration.
[FR Doc. 2016–16548 Filed 7–12–16; 8:45 am]
BILLING CODE 7510–13–P
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
[Notice: 16–053]
NASA Advisory Council; Meeting
National Aeronautics and
Space Administration.
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, Public
Law 92–463, as amended, the National
Aeronautics and Space Administration
(NASA) announces a meeting of the
NASA Advisory Council.
DATES: Thursday, July 28, 2016, 9:00
a.m.–5:00 p.m., Local Time; and Friday,
July 29, 2016, 9:00 a.m.–12:00 p.m.,
Local Time.
ADDRESSES: Ohio Aerospace Institute,
President’s Room, 22800 Cedar Point
Road, Cleveland, Ohio 44142.
FOR FURTHER INFORMATION CONTACT: Ms.
Marla King, NAC Administrative
Officer, NASA Headquarters,
Washington, DC 20546, (202) 358–1148.
SUPPLEMENTARY INFORMATION: This
meeting will be open to the public up
to the capacity of the meeting room.
SUMMARY:
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
NATIONAL FOUNDATION ON THE
ARTS AND THE HUMANITIES
National Endowment for the
Humanities
Meetings of Humanities Panel
National Endowment for the
Humanities, National Foundation on the
Arts and the Humanities.
ACTION: Notice of meetings.
AGENCY:
The National Endowment for
the Humanities will hold twenty-four
meetings of the Humanities Panel, a
federal advisory committee, during
August, 2016. The purpose of the
meetings is for panel review, discussion,
evaluation, and recommendation of
applications for financial assistance
under the National Foundation on the
Arts and Humanities Act of 1965.
DATES: See SUPPLEMENTARY INFORMATION
section for meeting dates. The meetings
will open at 8:30 a.m. and will adjourn
by 5:00 p.m. on the dates specified
below.
SUMMARY:
E:\FR\FM\13JYN1.SGM
13JYN1
]]>Agencies
[Federal Register Volume 81, Number 134 (Wednesday, July 13, 2016)]
[Notices]
[Page 45307]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-16550]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Noramco, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.34(a) on or before August 12, 2016. Such persons may also file a
written request for a hearing on the application pursuant to 21 CFR
1301.43 on or before August 12, 2016.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/ODW, 8701 Morrissette Drive,
Springfield, Virginia 22152. Comments and requests for hearings on
applications to import narcotic raw material are not appropriate. 72 FR
3417 (January 25, 2007).
SUPPLEMENTARY INFORMATION: The Attorney General has delegated her
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers importers, and exporters of,
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Deputy Assistant Administrator of the DEA Office of Diversion
Control (``Deputy Assistant Administrator'') pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on April
4, 2016, Noramco, Inc., 1440 Olympic Drive, Athens, Georgia 30601
applied to be registered as an importer of the following basic classes
of controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Phenylacetone (8501)....................... II
Thebaine (9333)............................ II
Poppy Straw Concentrate (9670)............. II
Tapentadol (9780).......................... II
------------------------------------------------------------------------
The company plans to import thebaine derivatives (9333) as
reference standards. The company plans to import an intermediate form
of tapentadol (9780) to bulk manufacture tapentadol for distribution to
its customers. The company plans to import phenylacetone (8501) and
poppy straw concentrate (9670) to manufacture other controlled
substances.
Dated: July 5, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-16550 Filed 7-12-16; 8:45 am]
BILLING CODE 4410-09-P
